Ark Invest’s Cathie Wood vindicated by revved-up Tesla

A little under a year ago, Cathie Wood named Tesla as her top stock pick for 2020 at the Sohn Hearts & Minds Conference. She pitched her bearish case, stating the stock price would double by 2024. It hit that milestone less than three months later.

Cliona O’Dowd

Ark Invest’s Cathie Wood vindicated by revved-up Tesla

September 16, 2020
A little under a year ago, Cathie Wood named Tesla as her top stock pick for 2020 at the Sohn Hearts & Minds Conference. She pitched her bearish case, stating the stock price would double by 2024. It hit that milestone less than three months later.
Read Transcript

A little under a year ago, Cathie Wood named Tesla as her top stock pick for 2020. Speaking at the Sohn Hearts & Minds Investment Leaders Conference in Sydney last November, Ms Wood, who runs US technology-focused investment firm Ark Invest, said her bearish case was that the stock price would double by 2024. It hit that milestone less than three months later.

Ms Wood was one of a handful of top investors and global thought leaders to present at the annual conference last year, which has to date raised $10m for Australian medical research.

This year, activist investor Bill Ackman, the founder and CEO of hedge fund Pershing Square Capital, will be the keynote speaker at the event, which is being held virtually for the first time in November.‍

Taking place just 10 days after the US election, the timing of the conference couldn’t be better, according to Rory Lucas, who runs the Hearts & Minds fund, which invests in 25-30 high conviction stocks, including the top 12 picks from the event each year.

“This presidential election is going to be controversial and it’s going to have big ramifications for markets and the world. A lot of people will want to know what the brains of the US market thinks about who the next president is,” Mr Lucas said.

While Mr Ackman has long been on the wishlist of speakers, it was the shift to a virtual event that allowed Hearts& Minds to secure him, as well as others who ordinarily wouldn’t have been able to attend a conference in Australia, Mr Lucas said.

“We’ve also asked Cathie Wood to come back because everyone’s going to want to know what she thinks. Everyone’s going to want to know what she thinks about Tesla now that it’s up 600 per cent.

“Everyone’s also going to want to know what else she’s doing. Her funds are just fascinating; she’s got five different disruptive technologies that she focuses her investments on. So people are going to want to know about it.”

Now in its fifth year, the conference gave people access to fund managers and investors they’d normally never get to hear from, Mr Lucas said.

“At TDM Growth Partners, Hamish Corlett and Tom Cowan have been extremely successful fund managers. They’ve only got 20 investors. If you rang them up and said, ‘I want to invest my money with you’, they’d say, ‘thanks, but no thanks’. They’re closed to investors, closed to money.”

Shifting it to a virtual event, meanwhile, made it more accessible to a wider audience, conference co-founder and former UBS Australia head Matthew Grounds said.

“We have, once again, a great line-up of fund managers and keynotes this year from both the US and the local community and we will be streaming the conference a week after the US election, so the timing couldn’t be better.

“This year’s conference will be more accessible as it will be virtual, so it provides an opportunity for a much wider audience and we are looking forward to sharing some of the best ideas from the brightest minds, all in benefit of Australian medical research.”

While the conference has raised $10m to date for medical research, Hearts & Minds Investments, a listed investment company, has raised another $10m. The fund managers involved waive their fees, allowing it to donate 1.5 per cent of net tangible assets each year.

Listed on the ASX in November 2018, Hearts & Minds has returned 51 per cent since inception, 26 per cent over the past 12 months, and 15 per cent since March.

There are two parts to the portfolio: the core portion, which accounts for 65 per cent and is made up of six managers, including Hamish Douglass and Peter Cooper, who each nominate their three best high-conviction stock picks; and the conference portion, which accounts for the remaining 35 per cent and is made up of the annual recommendations from the conference run each November.

The conference picks were held for a maximum of 12 months, with $20m being the standard investment in each, Mr Lucas said.

If a stock does really well, as Tesla did this year, the fund trims the position to take profits.

“We trimmed it as it rallied, then it fell all the way back when COVID-19 hit, so we were actually able to redeploy a full-sized position. Then it doubled again, and so we trimmed it again. It rose some more so we trimmed some more.”

Working with famous investors brought diversity to the fund, he said.

The Sohn Hearts & MindsInvestment Leaders conference will be held online on November 13.

 

This article was originally posted on The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

A little under a year ago, Cathie Wood named Tesla as her top stock pick for 2020. Speaking at the Sohn Hearts & Minds Investment Leaders Conference in Sydney last November, Ms Wood, who runs US technology-focused investment firm Ark Invest, said her bearish case was that the stock price would double by 2024. It hit that milestone less than three months later.

Ms Wood was one of a handful of top investors and global thought leaders to present at the annual conference last year, which has to date raised $10m for Australian medical research.

This year, activist investor Bill Ackman, the founder and CEO of hedge fund Pershing Square Capital, will be the keynote speaker at the event, which is being held virtually for the first time in November.‍

Taking place just 10 days after the US election, the timing of the conference couldn’t be better, according to Rory Lucas, who runs the Hearts & Minds fund, which invests in 25-30 high conviction stocks, including the top 12 picks from the event each year.

“This presidential election is going to be controversial and it’s going to have big ramifications for markets and the world. A lot of people will want to know what the brains of the US market thinks about who the next president is,” Mr Lucas said.

While Mr Ackman has long been on the wishlist of speakers, it was the shift to a virtual event that allowed Hearts& Minds to secure him, as well as others who ordinarily wouldn’t have been able to attend a conference in Australia, Mr Lucas said.

“We’ve also asked Cathie Wood to come back because everyone’s going to want to know what she thinks. Everyone’s going to want to know what she thinks about Tesla now that it’s up 600 per cent.

“Everyone’s also going to want to know what else she’s doing. Her funds are just fascinating; she’s got five different disruptive technologies that she focuses her investments on. So people are going to want to know about it.”

Now in its fifth year, the conference gave people access to fund managers and investors they’d normally never get to hear from, Mr Lucas said.

“At TDM Growth Partners, Hamish Corlett and Tom Cowan have been extremely successful fund managers. They’ve only got 20 investors. If you rang them up and said, ‘I want to invest my money with you’, they’d say, ‘thanks, but no thanks’. They’re closed to investors, closed to money.”

Shifting it to a virtual event, meanwhile, made it more accessible to a wider audience, conference co-founder and former UBS Australia head Matthew Grounds said.

“We have, once again, a great line-up of fund managers and keynotes this year from both the US and the local community and we will be streaming the conference a week after the US election, so the timing couldn’t be better.

“This year’s conference will be more accessible as it will be virtual, so it provides an opportunity for a much wider audience and we are looking forward to sharing some of the best ideas from the brightest minds, all in benefit of Australian medical research.”

While the conference has raised $10m to date for medical research, Hearts & Minds Investments, a listed investment company, has raised another $10m. The fund managers involved waive their fees, allowing it to donate 1.5 per cent of net tangible assets each year.

Listed on the ASX in November 2018, Hearts & Minds has returned 51 per cent since inception, 26 per cent over the past 12 months, and 15 per cent since March.

There are two parts to the portfolio: the core portion, which accounts for 65 per cent and is made up of six managers, including Hamish Douglass and Peter Cooper, who each nominate their three best high-conviction stock picks; and the conference portion, which accounts for the remaining 35 per cent and is made up of the annual recommendations from the conference run each November.

The conference picks were held for a maximum of 12 months, with $20m being the standard investment in each, Mr Lucas said.

If a stock does really well, as Tesla did this year, the fund trims the position to take profits.

“We trimmed it as it rallied, then it fell all the way back when COVID-19 hit, so we were actually able to redeploy a full-sized position. Then it doubled again, and so we trimmed it again. It rose some more so we trimmed some more.”

Working with famous investors brought diversity to the fund, he said.

The Sohn Hearts & MindsInvestment Leaders conference will be held online on November 13.

 

This article was originally posted on The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Sep 16, 2020. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November 2, 2023

Meet the 2023 Conference Managers

Following a rigorous global search, the Conference Fund Manager Selection Committee is pleased to share ten new managers for 2023.

Read More
Daniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: Bloomberg
October 23, 2023

Dan Loeb to headline Sohn Hearts & Minds

Famed hedge fund manager Dan Loeb has been named as one of the headline acts for next month’s Sohn Hearts & Minds philanthropic investment conference to be held in Sydney.

Read More
Ravi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn Licht
October 23, 2023

US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

Read More
October 18, 2023

Two small caps: Propel Funeral Services (ASX: PFP) and Clarity Pharmaceuticals (ASX: CU6)

Get to know our 2023 Conference Fund Manager Rikki Bannan of IFM Investors who recently featured on the Equity Mates Media podcast.

Read More
October 16, 2023

How this hedge fund pulled off 2023’s ‘big short’

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.

Read More
IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.
October 10, 2023

Beware the pitfalls of investing in healthcare, says IFM boss

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn’t necessarily proven to be the case,” she says in an interview ahead of her appearance at the Sohn Hearts & Minds Conference 2023.

Read More
October 6, 2023

Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.

Read More
Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.
September 18, 2023

‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.

Read More
September 15, 2023

Top fund managers share 11 stock picks for the long term

After a dramatic earnings season, fund managers, including Jessica Farr-Jones of Regal Funds and Kieran Moore of Munro Partners (HM1 Core Fund Managers), have shared some of their top picks for long-term growth.

Read More
September 11, 2023

Investors Sweeten On Hedge Funds As Rates Climb

After a decade of easy money pushing equity markets in one direction, Wall Street hedge fund manager Ricky Sandler says the return of volatility and higher interest rates is seeing money return to long-short strategies.

Read More
Eminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John Feder
September 11, 2023

Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.

Read More
Barrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter Rae
September 11, 2023

Top Ny Stock Picker Warns Inflation To Remain Above Pre-Covid Levels

Influential New York hedge fund manager Ricky Sandler of Eminence Capital returns for the 2023 Sohn Hearts & Minds Conference in Sydney and says no one is focused on picking interesting, idiosyncratic stocks.

Read More
August 4, 2023

New Relic

New Relic was pitched by Ricky Sandler of Eminence Capital at the 2022 Sohn Hearts & Minds Conference.

Read More
June 18, 2023

Investors can’t agree how to value the world’s hottest stock

Despite mixed investor opinions, Munro Partners (Core Fund Manager) remains a strong believer in Nvidia. They are standing firm in their investment and still consider it a solid buy.

Read More
June 8, 2023

Stock pickers bet the field in slowing domestic market

Fund managers have batted away fears of an inflation-led recession, with Qantas, Seven Group and Treasury Wines named among the best investments by Australia’s top stock pickers.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.